Protein disulfide isomerase family mediated redox regulation in cancer

Adv Cancer Res. 2023;160:83-106. doi: 10.1016/bs.acr.2023.06.001. Epub 2023 Jul 18.ABSTRACTProtein disulfide isomerase (PDI) and its superfamilies are mainly endoplasmic reticulum (ER) resident proteins with essential roles in maintaining cellular homeostasis, via thiol oxidation/reduction cycles, chaperoning, and isomerization of client proteins. Since PDIs play an important role in ER homeostasis, their upregulation supports cell survival and they are found in a variety of cancer types. Despite the fact that the importance of PDI to tumorigenesis remains to be understood, it is emerging as a new therapeutic target in cancer. During the past decade, several PDI inhibitors has been developed and commercialized, but none has been approved for clinical use. In this review, we discuss the properties and redox regulation of PDIs within the ER and provide an overview of the last 5 years of advances regarding PDI inhibitors.PMID:37704292 | PMC:PMC10586477 | DOI:10.1016/bs.acr.2023.06.001
Source: Advances in Cancer Research - Category: Cancer & Oncology Authors: Source Type: research